Literature DB >> 19401371

The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.

Margrit Urbanek1, Geetha Nampiaparampil, Janine D'Souza, Elizabeth Sefton, Christine Ackerman, Richard S Legro, Andrea Dunaif.   

Abstract

OBJECTIVE: We performed this study to test the hypothesis that variation in the lamin a/c gene (LMNA) contributes to milder phenotypes of insulin resistance, hyperandrogenism, and/or metabolic syndrome associated with polycystic ovary syndrome (PCOS). RESEARCH DESIGN AND METHODS: We resequenced the coding region, flanking intronic, and proximal promoter regions of the lamin a/c gene in 43 women with PCOS with evidence of upper-body obesity (waist circumference >88 cm) and identified 56 variants, two of which were nonsynonymous substitutions (lmna11 exon1 E98D; lmna24 exon 7 R455C). We genotyped 53 single-nucleotide polymorphisms (44 identified through resequencing and nine included to maximize informativeness of the entire gene) in 624 index (PCOS) cases and 544 controls of European ancestry. We tested for association between these variants and PCOS. In a subset of individuals, we also tested for association with metabolic syndrome and quantitative traits (body mass index, waist circumference, total testosterone, dehydroepiandrosterone sulfate, fasting glucose and insulin, low-density lipoprotein, and total triglycerides).
RESULTS: After correction for multiple testing, none of the variants showed significant evidence for association with PCOS, the metabolic syndrome, or any of the quantitative traits tested.
CONCLUSIONS: Whereas these studies cannot exclude the role of genetic variation in the lamin a/c gene in isolated cases of PCOS, we can conclude that common variation in the lamin a/c gene does not contribute to the etiology of PCOS in women of European ancestry.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19401371      PMCID: PMC2708953          DOI: 10.1210/jc.2008-2704

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

1.  Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Paulina A Essah; Teimuraz Apridonidze; Andrea Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

2.  Haploview: analysis and visualization of LD and haplotype maps.

Authors:  J C Barrett; B Fry; J Maller; M J Daly
Journal:  Bioinformatics       Date:  2004-08-05       Impact factor: 6.937

Review 3.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

Authors:  Scott M Grundy; James I Cleeman; Stephen R Daniels; Karen A Donato; Robert H Eckel; Barry A Franklin; David J Gordon; Ronald M Krauss; Peter J Savage; Sidney C Smith; John A Spertus; Fernando Costa
Journal:  Circulation       Date:  2005-09-12       Impact factor: 29.690

4.  Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin.

Authors:  M Urbanek; R S Legro; D A Driscoll; R Azziz; D A Ehrmann; R J Norman; J F Strauss; R S Spielman; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

Review 5.  Genetic basis of lipodystrophies and management of metabolic complications.

Authors:  Anil K Agarwal; Abhimanyu Garg
Journal:  Annu Rev Med       Date:  2006       Impact factor: 13.739

6.  Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Rhonda Bentley-Lewis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

7.  The peroxisome proliferator activated receptor gamma Pro12Ala polymorphism is associated with a lower hirsutism score and increased insulin sensitivity in women with polycystic ovary syndrome.

Authors:  Susanne Hahn; Anja Fingerhut; Ulyana Khomtsiv; Liliya Khomtsiv; Susanne Tan; Beate Quadbeck; Burkhard L Herrmann; Birgit Knebel; Dirk Müller-Wieland; Klaus Mann; Onno E Janssen
Journal:  Clin Endocrinol (Oxf)       Date:  2005-05       Impact factor: 3.478

8.  Type A insulin resistance syndrome revealing a novel lamin A mutation.

Authors:  Jacques Young; Louise Morbois-Trabut; Béatrice Couzinet; Olivier Lascols; Elisabeth Dion; Véronique Béréziat; Bruno Fève; Isabelle Richard; Jacqueline Capeau; Philippe Chanson; Corinne Vigouroux
Journal:  Diabetes       Date:  2005-06       Impact factor: 9.461

Review 9.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

10.  A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.

Authors:  R S Legro; D Finegood; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

View more
  4 in total

Review 1.  Review of Mendelian Randomization Studies on Endometrial Cancer.

Authors:  Jian-Zeng Guo; Qi-Jun Wu; Fang-Hua Liu; Chang Gao; Ting-Ting Gong; Gang Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-09       Impact factor: 6.055

2.  Plasminogen activator inhibitor-1 -675 4G/5G polymorphism and polycystic ovary syndrome risk: a meta analysis.

Authors:  Ying Liu; Mei-Guo Sun; Rong Jiang; Rui Ding; Zhen Che; Yan-Yan Chen; Ci-Jiang Yao; Xiao-Xia Zhu; Ji-Yu Cao
Journal:  J Assist Reprod Genet       Date:  2014-01-17       Impact factor: 3.412

3.  Evaluating reported candidate gene associations with polycystic ovary syndrome.

Authors:  Cindy Pau; Richa Saxena; Corrine Kolka Welt
Journal:  Fertil Steril       Date:  2013-01-30       Impact factor: 7.329

Review 4.  Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases.

Authors:  Alex Zhavoronkov; Zeljka Smit-McBride; Kieran J Guinan; Maria Litovchenko; Alexey Moskalev
Journal:  J Mol Med (Berl)       Date:  2012-10-23       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.